Home Health News Challenge trials can speed development of a Covid-19 vaccine – STAT – STAT

Challenge trials can speed development of a Covid-19 vaccine – STAT – STAT

12 min read
14
7

Human challenge trials, also known as controlled human infection models, are an essential tool for developing new vaccines. But unless we start preparing now for Covid-19 challenge trials by quickly manufacturing an unadulterated version of SARS-CoV-2, the virus that causes the disease, they might not be available in time to develop a vaccine against it.

Why on earth would anyone volunteer to be deliberately infected with a disease-causing pathogen, and even receive an experimental vaccine? I’ve been hearing a range of reasons from the 26,000-plus people from more than 100 countries that 1Day Sooner, an organization I helped found, has already registered to participate in a Covid-19 challenge trial down the road.

Some volunteers see challenge studies as akin to military service: “I signed up to serve in the army years ago for the betterment of the country and I am glad to do this again. People must be willing to take risks to get past this and it shouldn’t just be the poor.”

advertisement

Some want to feel to empowered to fight the disease: “I have a PhD in biomedical engineering working in cancer research but am not an essential worker and have felt mostly helpless during this time. I would be happy to risk infection for the sake of vaccine development.”

Some are just fed up with the virus: “I’m a health worker; a nurse to be specific. We want to get rid of this pandemic and go back to our normal lives. Sierra Leoneans are dying here and if this vaccine is not out early we will lose more lives.”

advertisement

The mission of 1Day Sooner is to advocate on behalf of challenge volunteers, which is somewhat different than advocating for the studies themselves. We want to help people participate in challenge studies that would accelerate a vaccine, but don’t want volunteers to take unnecessary risks that aren’t justified by a clear public benefit. My colleagues and I are optimistic that challenge trials will prove useful, although there are still questions about the applicability of a challenge study among young, healthy volunteers for a disease that mainly harms older people or those with heart disease, diabetes, and other health conditions.

But while the utility of challenge trials is not a foregone conclusion, there is no question that they have enormous potential value. Challenge trials established foundational elements of our understanding of the common cold and flu. The drug oseltamivir, better known as Tamiflu, was developed using challenge studies led by Dr. Fred Hayden in the late 1990s. More recently, vaccines for malaria, cholera, and typhoid have been approved that would likely have been impossible without the use of challenge trials. In fact, the first time a coronavirus was isolated in humans was in a common cold challenge study in 1965.

Our international research team elucidated a number of ways that challenge studies could extend our knowledge of Covid-19. They could identify correlates of protection — signs that the immune system is effectively fighting off the disease — that could then be targeted by vaccine candidates, helping conventional trials establish evidence that a vaccine would be effective earlier and with greater certainty. Challenge trials could provide an early (though imperfect) indicator of effectiveness that could help accelerate vaccine manufacture, possibly allowing for deployment months sooner and saving hundreds of thousands of lives and potentially trillions of dollars in economic activity.

Two arguments have recently been offered as reasons not to conduct challenge studies:

  • They will take too long to develop.
  • There currently are no rescue therapies for Covid-19 infection.

Considered carefully and in tandem, however, these points actually support organizing challenge trials now and taking steps like mass-producing the unattenuated (or “wild type”) virus under good manufacturing practices. If challenges are worthwhile only if a rescue therapy exists, it makes sense to start preparing for challenge trials now because a proven therapy might be available later. There are grounds for optimism, given the promising data about remdesivir published last week in the New England Journal of Medicine. And the Lancet recently published a report on the use of a triple-combination therapy of beta-1b, lopinavir-ritonavir, and ribavirin, which helped alleviate symptoms and shortened the duration of viral shedding and hospital stays by half in patients with mild-to-moderate Covid-19.

Even without a rescue therapy, the risks to young volunteers, while significant, are well within the range of choices like kidney donation or childbirth in the United States that people commonly make. Since more than 80% of Covid-19 deaths in New York City among those between the ages 18 to 45 involved preexisting conditions, for challenge tests that include only healthy volunteers who would be under constant medical observation, the real risk may be lower still.

As advocates of challenge testing, my colleagues and I would never undersell the risks, which are clearly meaningful. And knowledge about the disease is incomplete and evolving. But serving in the military or in a hospital amid a pandemic are also risky choices made under conditions of uncertainty. Just as it wouldn’t make sense to prevent health care workers from choosing to serve in hospitals during a pandemic, we should not prevent well-informed volunteers from taking risks to find a vaccine that works against SARS-CoV-2.

Uncertainty is a reason to be prepared, not an argument for paralysis. The vaccine development process has rightly proceeded with explosive acceleration, with Moderna’s candidate anticipated to begin Phase 3 trials just nine months after the first known case of Covid-19 was identified. The preparation of challenge trials should also be treated with similar Manhattan-Project-like urgency, given their potential value and the comparatively microscopic costs of preparation. Developing the challenge model and building needed biocontainment capacity would cost millions of dollars but might save tens of billions on unnecessary vaccine manufacturing alone. 1Day Sooner has secured interested funders to support producing the virus and has identified a vendor who has estimated it would take three to four months to make enough of the virus to start challenge testing. If the federal government provided meaningful support, that timeline could be accelerated significantly.

It may seem counterintuitive to think of urgency and caution in the same breath, but even those who oppose challenge trials without an identified rescue therapy must admit, once such a therapy exists, it would be better if challenge testing was ready for use rather than lagging far behind. Anything less is reckless behavior that endangers people who will die without a vaccine in the future and dishonors the sacrifice that challenge volunteers stand willing to take.

Josh Morrison is one of the founders of 1Day Sooner. He previously founded Waitlist Zero, an advocacy group for living organ donors, and the Rikers Debate Project.

Let’s block ads! (Why?)


Source link

14 Comments

  1. g know

    June 20, 2020 at 7:19 am

    Hey there! I simply wish to offer you a huge thumbs up for your great information you’ve got
    right here on this post. I am coming back to
    your blog for more soon.

    Reply

  2. rsacwgxy g

    June 22, 2020 at 3:47 pm

    This web site certainly has all the information I wanted concerning this subject and didn’t know who
    to ask.

    Reply

  3. best web hosting sites

    July 16, 2020 at 12:00 pm

    Excellent pieces. Keep writing such kind of info on your blog.
    Im really impressed by your site.
    Hi there, You’ve done a fantastic job. I’ll definitely digg
    it and for my part recommend to my friends. I’m
    sure they will be benefited from this web site.

    Reply

  4. best web hosting sites

    July 22, 2020 at 1:00 am

    I just couldn’t leave your site before suggesting that I extremely enjoyed the standard
    info a person supply to your guests? Is going to
    be again continuously to check up on new posts

    Reply

  5. hosting services

    August 7, 2020 at 12:35 pm

    That is really attention-grabbing, You’re an overly professional blogger.
    I’ve joined your rss feed and look ahead to in quest of extra of your excellent post.
    Also, I have shared your web site in my social networks

    Reply

  6. web hosting reviews

    August 10, 2020 at 6:02 am

    Post writing is also a excitement, if you be acquainted
    with after that you can write otherwise it
    is complicated to write.

    Reply

  7. cheap flights

    August 27, 2020 at 7:56 am

    This is very attention-grabbing, You are an excessively skilled blogger.
    I have joined your feed and sit up for searching for extra of
    your magnificent post. Additionally, I have shared your
    website in my social networks

    Reply

  8. ana

    March 14, 2021 at 2:00 pm

    Hi there, You’ve done a fantastic job. I will definitely digg it and personally recommend to my friends. I’m confident they will be benefited from this web site. Visit Our Site At: ana

    Reply

  9. Sharri Wardwell

    May 10, 2021 at 9:32 pm

    Have you ever heard of second life (sl for short). It is basically a video game where you can do anything you want. Second life is literally my second life (pun intended lol). If you would like to see more you can see these second life authors and blogs

    Reply

  10. best weed vaporizer 2020

    May 29, 2021 at 2:29 am

    Bong Coasters & Bong Pads dab bowl A one hitter dugout is one of the simplest ways to smoke legal herbs on the market. So while they are extremely convenient to use, the disadvantage is that it holds a relatively small amount of weed and needs to be refilled all the time if you tend to smoke frequently .

    Reply

  11. mini plastic bong

    May 29, 2021 at 4:18 am

    Dab Pads & Silicone Mats 1 hitter A one hitter dugout is one of the simplest ways to smoke legal herbs on the market. So while they are extremely convenient to use, the disadvantage is that it holds a relatively small amount of weed and needs to be refilled all the time if you tend to smoke frequently .

    Reply

  12. how to permanently cap off a water pipe

    May 30, 2021 at 7:51 am

    Bong Coasters & Bong Pads what is a honey straw We have secure servers and exchange zero customer information. The glass storage jar has 2.5 milimet thick sides and a super thick 7 mm bottom. The glass has to be made to exact dimensions in order to for all the pieces to fit together correctly. .

    Reply

  13. John Suganuma

    June 6, 2021 at 11:00 am

    This was awesome! I would like you to clean up all this spam though

    Reply

  14. Chet Kleinpeter

    June 10, 2021 at 7:51 am

    This was great! I would like you to clean up all this spam though

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

British Nutrition Foundation to launch Healthy Eating Week – New Food

The BNF is launching a new event to encourage people from all ages to improve their health…